USAPI Pharma is mission-driven to strengthen America’s pharmaceutical supply chain and safeguard national security. We are advancing ABRE™ (Adaptive Biothreat Response Ecosystem, patent-pending), a first-of-its-kind intelligence platform delivering early warning of drug supply vulnerabilities before they escalate into crises. Our focus is clear: reshore critical medicine manufacturing, protect military readiness, and ensure reliable access to life-saving medicines. Through strategic partnerships and government alignment, USAPI Pharma is positioned to deliver scalable, dual-use solutions for both national security and commercial healthcare.
| Employees | 1 (1 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular USAPI Pharma employee's phone or email?
Andy Chance is the Board Member - CEO of USAPI Pharma.
1 people are employed at USAPI Pharma.